Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siddhartha Yadav

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 24, 2019
Survival and prognostic factors in patients with pancreatic squamous cell carcinomaSri Harsha Tella, Anuhya Kommalapati, Siddhartha Yadav, et al.
Urologic Oncology|November 9, 2021
Collecting duct carcinoma: A single-institution retrospective studyZhuoer Xie, Siddhartha Yadav, Christine M Lohse, et al.
Gynecologic Oncology|September 6, 2024
Physical and psychological distress amongst patients undergoing neoadjuvant chemotherapy for advanced ovarian cancerShilpa Mokshagundam, Michaela E McGree, Amanda L Tapia, et al.
Gynecologic Oncology|June 15, 2026
Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomesRiham Suleiman, Shilpa Mokshagundam, Matthew S Block, et al.
Journal of Gastrointestinal Oncology|June 12, 2019
Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinomaSakti Chakrabarti, Sri Harsha Tella, Anuhya Kommalapati, et al.
Head & Neck|July 16, 2013
Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapyAndrew M Baschnagel, Siddhartha Yadav, Ovidiu Marina, et al.
Gynecologic Oncology|April 8, 2025
ECPPF stratification identifies occult high-risk subgroups in stage I, grade 1 or 2, ≤50 % invasive endometrial cancer: Candidates for adjuvant therapyJesus Gonzalez-Bosquet, Maryam Shahi, Siddhartha Yadav, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 17, 2023
Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research RetreatAkeem R Lewis, Grace M Choong, Elizabeth Cathcart-Rake, et al.
Cancers|April 3, 2021
Aspirin and Statin Use and the Risk of Gallbladder CancerKritika Prasai, Sri Harsha Tella, Siddhartha Yadav, et al.
Cancer Research|July 14, 2022
Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort StudyFei Chen, Sungshim L Park, Lynne R Wilkens, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 24, 2019
Survival and prognostic factors in patients with pancreatic squamous cell carcinomaSri Harsha Tella, Anuhya Kommalapati, Siddhartha Yadav, et al.
Urologic Oncology|November 9, 2021
Collecting duct carcinoma: A single-institution retrospective studyZhuoer Xie, Siddhartha Yadav, Christine M Lohse, et al.
Gynecologic Oncology|September 6, 2024
Physical and psychological distress amongst patients undergoing neoadjuvant chemotherapy for advanced ovarian cancerShilpa Mokshagundam, Michaela E McGree, Amanda L Tapia, et al.
Gynecologic Oncology|June 15, 2026
Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomesRiham Suleiman, Shilpa Mokshagundam, Matthew S Block, et al.
Journal of Gastrointestinal Oncology|June 12, 2019
Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinomaSakti Chakrabarti, Sri Harsha Tella, Anuhya Kommalapati, et al.
Head & Neck|July 16, 2013
Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapyAndrew M Baschnagel, Siddhartha Yadav, Ovidiu Marina, et al.
Gynecologic Oncology|April 8, 2025
ECPPF stratification identifies occult high-risk subgroups in stage I, grade 1 or 2, ≤50 % invasive endometrial cancer: Candidates for adjuvant therapyJesus Gonzalez-Bosquet, Maryam Shahi, Siddhartha Yadav, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 17, 2023
Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research RetreatAkeem R Lewis, Grace M Choong, Elizabeth Cathcart-Rake, et al.
Cancers|April 3, 2021
Aspirin and Statin Use and the Risk of Gallbladder CancerKritika Prasai, Sri Harsha Tella, Siddhartha Yadav, et al.
Cancer Research|July 14, 2022
Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort StudyFei Chen, Sungshim L Park, Lynne R Wilkens, et al.
Pageof 13